Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19. What are the five things that every cardiologist needs to know about vaccines? Read a brand new #JACCBTS to learn: https://t.co/slrGhnLrss https://t.co/hd9r922R8E
RNA Vaccines for COVID-19: 5 Things Every Cardiologist Should Know.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Nov 2020 – Jul 2022Where it's discussed
-
X / Twitter17 posts
-
News3 articles
-
YouTube2 videos
-
Facebook2 posts
AI synopsis
What people are saying
The discussions reflect a recognition of the publication as a valuable resource, with posts emphasizing the relevance of vaccine side effects, trial exclusions, and regulatory approvals. Words like 'must know' and references to official journal articles contribute to a tone of seriousness and professional curiosity, indicating a moderate yet meaningful impact on clinicians' awareness.
Most discussions acknowledge the importance of the publication and support the need for cardiologists to understand RNA vaccines, indicating general agreement.
The posts express moderate interest by highlighting key points and sharing links, suggesting active engagement but not overwhelming enthusiasm.
Comments include questions about trial inclusion and references to official sources, showing a reasonably deep level of discussion.
The emphasis on clinical implications and questions about immune response and side effects suggest that these discussions could influence professional understanding and practice.
Abstract in brief
- RNA vaccines for COVID-19, like Pfizer and Moderna, work by instructing cells to produce a protein that triggers an immune response, helping bodies fight the virus more effectively.
- These vaccines have shown high effectiveness in preventing severe illness and hospitalization, but they can cause temporary side effects such as soreness, fatigue, or mild flu-like symptoms.
- Cardiologists should be aware of the potential rare side effects, like myocarditis, especially in young males, and understand how to counsel patients about vaccine benefits and risks.]
Top posts
Most liked on X and BlueskyLo que todo Cardiologo debe saber sobre las A From @jaccjournals https://t.co/lpgpvgzH3T
RNA Vaccines for COVID-19: 5 Things Every Cardiologist Should know #6 in the newsletter https://t.co/tfeef3D7Yb https://t.co/Ezj1SM22mW
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
RT @igormorr: Lo que todo Cardiologo debe saber sobre las A From @jaccjournals https://t.co/lpgpvgzH3T
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
All mentions
Impact of COVID-19 on Cardiovascular Disease Patients and Treatments
This video discusses the heightened impact of COVID-19 on patients with cardiovascular disease. It reviews a study of 8,910 hospitalized patients, emphasizing mortality risks and the effects of ACE inhibitors and ARBs…
COVID-19 Vaccination Insights for Healthcare Professionals
This audio project offers a comprehensive overview of COVID-19 vaccination, addressing its implications for patients with cardiovascular disease. It serves as an educational resource tailored for healthcare students to…
RT @igormorr: Lo que todo Cardiologo debe saber sobre las A From @jaccjournals https://t.co/lpgpvgzH3T
RT @igormorr: Lo que todo Cardiologo debe saber sobre las A From @jaccjournals https://t.co/lpgpvgzH3T
RT @igormorr: Lo que todo Cardiologo debe saber sobre las A From @jaccjournals https://t.co/lpgpvgzH3T
Lo que todo Cardiologo debe saber sobre las A From @jaccjournals https://t.co/lpgpvgzH3T
@HSJEditor @MHRAgovuk Lin C-J, Mecham RP, Mann DL, RNA Vaccines for COVID-19: Five Things Every Cardiologist Should Know, JACC: Basic to Translational Science (2020), doi: https:// https://t.co/atbRMi5S4l. check immunocompromised section...included in p.3 trial or not?
Can @pfizer / @BioNTech_Group advise if "immunocompromised/suppressed patients" excluded from p.3 trials per below? A contra-indication? @guardian Lin C-J, Mecham RP, Mann DL, JACC: Basic to Translational Science (2020), doi: https:// https://t.co/atbRMi5S4l.
RT @thePagerNews: RNA Vaccines for COVID-19: 5 Things Every Cardiologist Should know #6 in the newsletter https://t.co/tfeef3D7Yb https://…
RNA Vaccines for COVID-19: 5 Things Every Cardiologist Should know #6 in the newsletter https://t.co/tfeef3D7Yb https://t.co/Ezj1SM22mW
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
RT @JACCJournals: Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19.…
Two different RNA vaccines will likely be granted emergency use authorization by the FDA for the prevention of #COVID19. What are the five things that every cardiologist needs to know about vaccines? Read a brand new #JACCBTS to learn: https://t.co/slrGhnLrss https://t.co/hd9r922R8E